Effect of Qingfei Paidu decoction combined with Western medicine treatments for COVID-19: A systematic review and meta-analysis

Cao, 2020, A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19, N. Engl. J. Med., 382, 1787, 10.1056/NEJMoa2001282 Cao, 2020, The important role of polysaccharides from a traditional Chinese medicine-lung cleansing and detoxifying decoction against the COVID-19 pandemic, Carbohydr. Polym., 240, 10.1016/j.carbpol.2020.116346 Chen, 2020, Protection against COVID-19 injury by Qingfei Paidu Decoction via anti-viral, anti-inflammatory activity and metabolic programming, Biomed. Pharmacother., 129, 10.1016/j.biopha.2020.110281 Chen, 2020, Qingfei Paidu Decoction”—A possible choice of phytotherapy for severe acute respiratory infection caused by coronavirus disease-19, Am. J. Plant. Sci., 11, 1111, 10.4236/ajps.2020.117079 Chen, 2021, Qingfei Paidu Decoction combined with Western medicine routine treatment for coronavirus disease 2019 (COVID-19) concomitant with chronic hepatitis b: A multi-center retrospective study, J. Tradit. Chin. Med., 62, 1694 Fan, 2020, Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis, J. Integr. Med., 18, 385, 10.1016/j.joim.2020.07.008 Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 Higgins, 2020, Cochrane handbook for systematic reviews of interventions version 6.1 (updated september 2020), Cochrane, 2020 Hu, 2020, Efficacy and safety of lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial, Phytomedicine, 85 Hariyanto, 2021, Ivermectin and outcomes from COVID-19 pneumonia: A systematic review and meta-analysis of randomized clinical trial studies, Rev. Med. Virol., 32, e2265, 10.1002/rmv.2265 Hariyanto, 2021, Efficacy and safety of tocilizumab for coronavirus disease 2019 (COVID-19) Patients: A systematic review and meta-analysis, Drug. Res., 71, 265, 10.1055/a-1336-2371 Hariyanto, 2021, Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection, J. Med. Virol., 93, 1832, 10.1002/jmv.26698 Ioannidis, 2007, Heterogeneity in meta-analyses of genome-wide association investigations, PLoS One, 2, e841, 10.1371/journal.pone.0000841 Jang, 2021, Telemedicine and the use of Korean medicine for patients with COVID-19 in South Korea: Observational study, JMIR Public Health Surveill, 7, e20236, 10.2196/20236 Ji, 2021, Clinical characteristics and treatment outcome of COVID-19 patients with stroke in China: A multicenter retrospective study, Phytomedicine, 81, 10.1016/j.phymed.2020.153433 Kang, 2020, The effects of Qingfei Paidu Decoction on coronavirus disease-19: A narrative review, J. Inter. Kor. Med., 41, 424, 10.22246/jikm.2020.41.3.424 Kageyama, 2021, Qingfei Paidu Decoction, a Chinese herbal medicine against COVID‑19, elevates the blood levels of pro‑inflammatory cytokines: An open‑label, single‑arm pilot study, WASJ, 3, 1 Khanna, 2021, Herbal immune-boosters: Substantial warriors of pandemic COVID-19 battle, Phytomedicine, 85, 10.1016/j.phymed.2020.153361 Komoda, 2021, For safer use of ivermectin in all patients, Yakugaku zasshi, 141, 887, 10.1248/yakushi.20-00242 Li, 2017, Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects, J. Ethnopharmacol., 198, 45, 10.1016/j.jep.2016.12.042 Li, 2020, Observation on clinical effect of modified Qingfei Paidu Decoction in treatment of COVID-19, Chin. Tradit. Herb. Drug, 51, 2046 Li, 2020, Evaluation on the clinical effect of traditional Chinese medicine and western medicine regimens on COVID-19, Guangming J. Chin. Med., 35, 1273 Liu, 2020, Efficacy and safety of integrated traditional Chinese and Western medicine for corona virus disease 2019 (COVID-19): a systematic review and meta-analysis, Pharmacol. Res., 158, 10.1016/j.phrs.2020.104896 Liu, 2021, Qingfei Paidu Decoction for COVID-19: A bibliometric analysis, Biomed. Environ. Sci., 34, 755 Liu, 2021, Efficacy of Qingfei Paidu Decoction on patients with COVID-19 pneumonia in wuhan, China: A propensity score matching study, Evid. Based Complementary Altern. Med. Luo, 2021, Characteristics of registered clinical trials on traditional Chinese medicine for coronavirus disease 2019 (COVID-19): A scoping review, Eur. J. Integr. Med., 41, 10.1016/j.eujim.2020.101251 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, 1, 10.1371/journal.pmed.1000097 Ma, 2020, Association of overlapped and un-overlapped comorbidities with COVID-19 severity and treatment outcomes: A retrospective cohort study from nine provinces in China, Biomed. Environ. Sci., 33, 893 Ma, 2021, The relationship between time to a high COVID-19 response level and timing of peak daily incidence: an analysis of governments' stringency index from 148 countries, Infect. Dis. Poverty, 10, 96, 10.1186/s40249-021-00880-x 2020 2020 Ni, 2020, Combating COVID-19 with integrated traditional Chinese and Western medicine in China, Acta Pharm. Sin. B, 10, 1149, 10.1016/j.apsb.2020.06.009 Pan, 2020, Repurposed antiviral drugs for COVID-19 - Interim WHO solidarity trial results, N. Engl. J. Med., 6, 497 Ren, 2020, Traditional Chinese medicine for COVID-19 treatment, Pharmacol. Res., 155 Slim, 2003, Methodological index for non-randomized studies (MINORS): development and validation of a new instrument, ANZ J. Surg., 73, 712, 10.1046/j.1445-2197.2003.02748.x 2020 Shi, 2020, Association between early treatment with Qingfei Paidu Decoction and favorable clinical outcomes in patients with COVID-19: A retrospective multicenter cohort study, Pharmacol. Res., 161, 1, 10.1016/j.phrs.2020.105290 Sun, 2021, Multicenter clinical research of Qingfei Paidu Decoction in 295 cases in the treatment of COVID-19, J. Tradit. Chin. Med., 7, 599 Tian, 2020, Hanshiyi Formula, a medicine for Sars-CoV-2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study, Pharmacol. Res., 161, 10.1016/j.phrs.2020.105127 Wang, 2020, Clinical observation on Qingfei Paidu Decoction in treating COVID-19, Chin. Med. Pharm. Clin., 36, 13 Wang, 2021, Clinical effects of Qingfei Paidu Decoction combined with conventional treatment on patients with coronavirus disease 2019, Chin. Tradit. Pat. Med., 43, 656 Wang, 2021, Efficacy and safety of Qingfei Paidu Decoction for treating COVID-19: A systematic review and meta-analysis, Front. Pharm., 12 Xin, 2020, Clinical retrospective study on the efficacy of Qingfei Paidu Decoction combined with Western medicine for COVID-19 treatment, Biomed. Pharmacother., 129, 10.1016/j.biopha.2020.110500 Xiong, 2020, Chinese herbal medicine for coronavirus disease 2019: A systematic review and meta-analysis, Pharmacol. Res., 160, 10.1016/j.phrs.2020.105056 Xu, 2020, Mechanism of Qingfei Paidu Decoction on COVID-19 based on network pharmacology, Pharmacol. Clin. Tradit. Chin. Med., 36, 26 Yu, 2020, Efficacy study of arbidol, Qingfei Paidu Decoction, Lianhuaqingwen Capsule, and Jinye Baidu Granules in the treatment of mild/moderate COVID-19 in a fangcang shelter hospital, Pharmacol. Clin. Chin. Materia. Med., 36, 2 Yu, 2020, Comparison of clinical efficacy of Qingfei Paidu Decoction combined with Western medicine in 43 cases and single Western medicine in 46 cases in the treatment of COVID-19, J. Shandong Univ. Health Sci., 58, 47 Yue, 2012, Analysis of TCM epidemic diseases pathogenic theory, J. Tradit. Chin. Med., 27, 3044 Zeng, 2012, Meta analysis series 7: quality assessment tools for nonrandomized experimental studies, diagnostic trials, and animal trials, Chin. J. Evid. Based Cardiovasc. Med., 4, 496 Zeng, 2020, Effect of Qingfei Paidu Decoction on clinical efficacy of COVID-19 pneumonia with phlegm heat blocking lung, Med. J. West China, 32 Zhao, 2020, Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qingfei Paidu Decoction in the treatment of COVID-19, Phytomedicine, 85 Zhong, 2020, Potential targets for treatment of coronavirus disease 2019 (COVID-19): A review of Qingfei Paidu Decoction and its major herbs, Am. J. Chin. Med., 48, 1051, 10.1142/S0192415X20500512 Zhang, 2021, Association between use of Qingfei Paidu Decoction and mortality in hospitalized patients with COVID-19: A national retrospective registry study, Phytomedicine, 85, 10.1016/j.phymed.2021.153531 Zhang, 2021, Clinical study on the improvement of inflammatory cytokines in critically ill patients with COVID-19 treated by Qingfei Paidu Decoction, Mod. Tradit. Chin. Med.-WST, 23, 391